Профиль компании · Healthcare

Option Care Health Inc

OPCH · США
Страна / Регион
USA
Дата IPO
15 августа 1996 г.
Сотрудники
8 000
Buffett Score
38/100
Слабоватый
Капитализация3,39 млрд $
Выручка (TTM)5,69 млрд $
EBITDA405,09 млн $
Чистая маржа3,68 %
ROE16 %
P/E (TTM)17,15
Прогнозный P/E11,22
PEG1,12
Прибыль на акцию1,32 $
Диапазон за 52 недели18,01 $ – 36,80 $
Целевая цена аналитиков28,58 $
Рейтинг аналитиков3.9 / 5

Данные EODHD, показаны в валюте отчётности; только для справки, не является инвестиционной рекомендацией.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

История

СкороЭтот раздел заполняется — загляните позже.

Положение в отрасли

СкороЭтот раздел заполняется — загляните позже.

Аналитики по этой бумаге на вашем языке пока нет.